Main Menu

Applied Molecular Transport Inc.


Rigrodsky Law, P.A. is investigating Applied Molecular Transport Inc. (“Applied Molecular”) regarding possible breaches of fiduciary duties and other violations of law related to Cambridge’s agreement to be acquired by Cyclo Therapeutics, Inc. (“Cyclo”). Under the terms of the agreement, Applied Molecular shareholders will receive 0.174 shares of Cyclo’s common stock for each share of Applied Molecular common stock owned.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 04/24/2024

* Indicates a required field.

Back to Page